| abstract |
(57) [Summary]nThe present invention provides a lyophilized composition of an obese protein. This composition exhibits remarkable stability and manufacturability and, importantly, helps in the preparation of a stable pharmaceutical formulation useful in treating patients in need thereof. Accordingly, the present invention further provides methods of using such formulations for the treatment of obesity and diseases associated with obesity, such as diabetes, cardiovascular disease and cancer. |